ABT - Abbott Laboratories

NYSE - NYSE Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
12/30/2015
Total Revenue
31,355,000
30,578,000
27,390,000
20,853,000
20,405,000
Cost of Revenue
12,988,000
12,706,000
12,337,000
9,024,000
8,747,000
Gross Profit
18,367,000
17,872,000
15,053,000
11,829,000
11,658,000
Operating Expenses
Research Development
2,407,000
2,300,000
2,235,000
1,422,000
1,405,000
Selling General and Administrative
9,711,000
9,744,000
9,117,000
6,672,000
6,785,000
Total Operating Expenses
14,059,000
14,222,000
13,327,000
8,644,000
8,791,000
Operating Income or Loss
4,308,000
3,650,000
1,726,000
3,185,000
2,867,000
Interest Expense
-
826,000
904,000
431,000
163,000
Total Other Income/Expenses Net
65,000
-56,000
1,285,000
-1,440,000
374,000
Income Before Tax
3,784,000
2,873,000
2,231,000
1,413,000
3,183,000
Income Tax Expense
491,000
539,000
1,878,000
350,000
577,000
Income from Continuing Operations
3,293,000
2,334,000
353,000
1,063,000
2,606,000
Net Income
3,292,000
2,368,000
477,000
1,400,000
4,423,000
Net Income available to common shareholders
3,292,000
2,368,000
477,000
1,400,000
4,423,000
Reported EPS
Basic
-
1.35
0.27
0.95
3.00
Diluted
-
1.33
0.27
0.94
2.92
Weighted average shares outstanding
Basic
-
1,755,619
1,743,602
1,472,869
1,472,665
Diluted
-
1,770,000
1,749,000
1,483,000
1,506,000
EBITDA
-
6,977,000
6,156,000
3,197,000
3,468,000